Is Drug Testing Important in Addiction Treatment?

Drug Testing Has a Complicated History

Drug testing has been part of addiction treatment for decades, but it has not always been used in a helpful or patient-centered way.

In some settings, an unexpected result has been treated as proof that a patient is dishonest, unmotivated, or “not ready” for treatment. Patients may have been shamed, moved backward in a program, denied medication, or discharged from care altogether. Testing can begin to feel less like a medical tool and more like surveillance or punishment.

That history matters. People are less likely to be honest with their treatment team when they believe one difficult conversation or unexpected result could cost them access to care.

A Drug Test Result Is Information, Not a Verdict

A drug test can tell us that a substance—or one of its metabolites—was detected in a particular sample. It cannot tell us the entire story.

A positive result does not automatically explain when the substance was used, how much was used, why it was used, or whether the patient is currently intoxicated or impaired. Screening tests can also have limitations, including substances they do not detect reliably and medications that can occasionally produce unexpected results.

The appropriate response is usually a conversation:

• Was the result expected?

• Does it fit with what the patient reports?

• Could a prescribed or over-the-counter medication have affected it?

• Does the result need confirmation?

• Does it reveal a new safety concern?

• What should change in the treatment plan?

The test should contribute to clinical judgment. It should not replace it.

Returning to Use Is Often When Treatment Matters Most

Addiction is a condition in which returning to substance use can be part of the illness. That does not mean a return to use should be ignored or treated as harmless. It means it should lead to reassessment rather than automatic rejection.

Someone who has returned to opioid use may be at increased risk of overdose. Someone combining opioids with benzodiazepines or alcohol may face additional danger. Someone who has resumed stimulant use may need more frequent contact, help managing sleep or psychiatric symptoms, or a different level of support.

Removing that person from treatment may also remove access to medication, naloxone, counseling, medical advice, and a clinician who knows them. In many cases, the unexpected result is evidence that treatment needs to become more responsive—not that treatment should end.

So Why Perform Drug Testing at All?

Recognizing the harms of punitive testing does not mean drug testing has no value.

Patient reports are important and should be taken seriously. At the same time, memory can be imperfect, substances may contain ingredients the patient did not expect, and fear of consequences can make complete disclosure difficult. Objective information can sometimes identify risks that would otherwise remain hidden.

Drug testing may help a clinician:

• identify an unexpected substance;

• recognize dangerous combinations of substances;

• confirm that a prescribed medication appears to be present;

• evaluate whether treatment is moving in the right direction;

• decide whether follow-up should become more or less frequent;

• begin a conversation about a result that does not match expectations.

The purpose should be clear before the test is ordered. Testing simply because “we always do it” is less useful than testing because the result could meaningfully inform care.

Accountability Can Build Trust

Drug testing is sometimes described as evidence that the treatment team does not trust the patient. We see it differently.

Trust in addiction treatment does not have to mean relying on words alone or pretending that setbacks cannot happen. Trust can grow through a consistent process in which expectations are explained in advance, patients are treated honestly and respectfully, and unexpected results are addressed without humiliation.

Accountability builds trust when everyone understands:

• what is being monitored;

• why it matters;

• how the information will be used;

• what is likely to happen if a result is unexpected.

When patients know that honesty will lead to problem-solving rather than automatic punishment, it becomes easier to talk openly. Over time, reported substance use, medication monitoring, appointment attendance, and test results can create a fuller and more reliable picture together.

Testing should not be used as a trap. It should be one part of a shared structure that allows both the patient and the clinician to make safer decisions.

Results Should Change Care, Not End It

An unexpected result should prompt the clinician to ask what the result means for this particular patient.

Sometimes no major change is needed beyond discussing the result. In other situations, the treatment plan may need to include:

• more frequent follow-up;

• additional or confirmatory testing;

• renewed overdose-prevention counseling;

• making sure naloxone is available;

• adjusting a medication;

• addressing cravings or withdrawal symptoms;

• involving counseling, peer support, or family support;

• evaluating whether a more intensive level of care is appropriate.

There can be circumstances in which a particular clinic cannot safely provide the level of care someone needs. A patient may require medically supervised withdrawal, residential treatment, emergency evaluation, or another specialized setting. Even then, the goal should be an appropriate transition in care—not abandonment as a punishment for the test result.

What About Medication Adherence and Diversion?

Drug testing can also play a limited role in determining whether a prescribed addiction medication appears to be present.

For example, testing for buprenorphine and its metabolites may provide useful information when there is concern that medication is not being taken as prescribed or is being diverted. However, these results are not perfect lie detectors. They must be interpreted alongside the timing of the last dose, the type of test, prescription-monitoring information, attendance, medication counts when appropriate, and the overall clinical picture.

Diversion prevention is a legitimate responsibility in addiction medicine. Buprenorphine and other controlled medications should be prescribed carefully and monitored responsibly. But efforts to prevent diversion should remain proportional to the actual concern and should not make effective treatment unnecessarily difficult to access.

The goal is to protect both the individual patient and the community without approaching every patient as though diversion has already occurred.

Not Every Patient Needs the Same Testing Forever

Drug testing should be individualized just like the rest of addiction treatment.

A patient who is new to treatment, experiencing frequent returns to use, taking medications with important safety concerns, or struggling to attend appointments may reasonably need closer monitoring. Someone who has demonstrated sustained stability may need less frequent testing and fewer restrictions.

Testing frequency should be able to move in both directions.

When risk increases, monitoring may temporarily become more intensive. When stability, communication, and consistency grow over time, monitoring should generally become less burdensome. This gives accountability a purpose: it creates a pathway toward greater trust and flexibility rather than becoming a permanent system of suspicion.

How Shoreline Thinks About Drug Testing

We believe drug testing can be an important part of addiction treatment—but the purpose and response matter as much as the test itself.

Testing should help identify risk, support medication safety, provide accountability, and guide treatment decisions. It should be interpreted in context and discussed openly with the patient. An unexpected result may mean that more support, a different plan, or closer follow-up is needed.

It should not automatically mean that the patient loses access to care.